BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 10657489)

  • 1. Tachykinin NK(3)receptor involvement in anxiety.
    Ribeiro SJ; Teixeira RM; Calixto JB; De Lima TC
    Neuropeptides; 1999 Apr; 33(2):181-8. PubMed ID: 10657489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Respiratory actions of tachykinins in the nucleus of the solitary tract: characterization of receptors using selective agonists and antagonists.
    Mazzone SB; Geraghty DP
    Br J Pharmacol; 2000 Mar; 129(6):1121-31. PubMed ID: 10725260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of central administration of tachykinin receptor agonists and antagonists on plus-maze behavior in mice.
    Teixeira RM; Santos AR; Ribeiro SJ; Calixto JB; Rae GA; De Lima TC
    Eur J Pharmacol; 1996 Sep; 311(1):7-14. PubMed ID: 8884230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study of SR 142801, a new potent non-peptide NK3 receptor antagonist on cardiovascular responses in conscious guinea-pig.
    Roccon A; Marchionni D; Nisato D
    Br J Pharmacol; 1996 Jul; 118(5):1095-102. PubMed ID: 8818331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurokinin B- and specific tachykinin NK(3) receptor agonists-induced airway hyperresponsiveness in the guinea-pig.
    Daoui S; Naline E; Lagente V; Emonds-Alt X; Advenier C
    Br J Pharmacol; 2000 May; 130(1):49-56. PubMed ID: 10780997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular and behavioural effects of intracerebroventricularly administered tachykinin NK3 receptor antagonists in the conscious rat.
    Cellier E; Barbot L; Regoli D; Couture R
    Br J Pharmacol; 1997 Oct; 122(4):643-54. PubMed ID: 9375960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tachykinin-induced contraction of the guinea-pig isolated oesophageal mucosa is mediated by NK(2) receptors.
    Kerr KP; Thai B; Coupar IM
    Br J Pharmacol; 2000 Dec; 131(7):1461-7. PubMed ID: 11090121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Central tachykinin NK3 receptors in the inhibitory action on the rat colonic propulsion of a new tachykinin, PG-KII.
    Broccardo M; Improta G; Tabacco A
    Eur J Pharmacol; 1999 Jul; 376(1-2):67-71. PubMed ID: 10440091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are biological actions of neurokinin A in the adult brain mediated by a cross-talk between the NK1 and NK2 receptors?
    Tauer U; Zhao Y; Hunt SP; Culman J
    Neuropharmacology; 2012 Nov; 63(6):958-65. PubMed ID: 22771977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for involvement of NK₃ receptors in the anxiogenic-like effect of SP6-11(C-terminal), a metabolite of substance P, in rats evaluated in the elevated plus-maze.
    Duarte FS; Duzzioni M; Leme LR; Smith Sde P; De Lima TC
    Behav Brain Res; 2016 Apr; 303():168-75. PubMed ID: 26851555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of cardiac activity by tachykinins in the rat substantia nigra.
    Lessard A; Couture R
    Br J Pharmacol; 2001 Dec; 134(8):1749-59. PubMed ID: 11739252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Senktide-induced gerbil foot tapping behaviour is blocked by selective tachykinin NK1 and NK3 receptor antagonists.
    Sundqvist M; Kristensson E; Adolfsson R; Leffler A; Ahlstedt I; Engberg S; Drmota T; Sigfridsson K; Jussila R; de Verdier J; Novén A; Johansson A; Påhlman I; von Mentzer B; Lindström E
    Eur J Pharmacol; 2007 Dec; 577(1-3):78-86. PubMed ID: 17920583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of selective tachykinin-receptor antagonists on tachykinin-induced airway mucus secretion in the rat.
    Wagner U; Fehmann H; Bredenbröker D; Klüber D; Lange A; Wichert P
    Neuropeptides; 1999 Feb; 33(1):55-61. PubMed ID: 10657472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contractile effect of tachykinins on Suncus murinus (house musk shrew) isolated ileum.
    Cheng FH; Chan SW; Rudd JA
    Neuropeptides; 2008; 42(5-6):671-9. PubMed ID: 18582934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurokinin A and senktide attenuate scopolamine-induced impairment of spontaneous alternation performance in mice.
    Ukai M; Shinkai N; Kameyama T
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1996 Jun; 16(3):97-101. PubMed ID: 8905797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro and in vivo characterization of NK3 receptors in the rabbit eye by use of selective non-peptide NK3 receptor antagonists.
    Medhurst AD; Hay DW; Parsons AA; Martin LD; Griswold DE
    Br J Pharmacol; 1997 Oct; 122(3):469-76. PubMed ID: 9351503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diverse effects of tachykinins on luteinizing hormone release in male rats: mechanism of action.
    Kalra PS; Sahu A; Bonavera JJ; Kalra SP
    Endocrinology; 1992 Sep; 131(3):1195-201. PubMed ID: 1380435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The ventral tegmental area as a putative target for tachykinins in cardiovascular regulation.
    Deschamps K; Couture R
    Br J Pharmacol; 2005 Jul; 145(6):712-27. PubMed ID: 15895109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The tachykinin NK3 receptor agonist senktide induces locomotor activity in male Mongolian gerbils.
    Nordquist RE; Durkin S; Jacquet A; Spooren W
    Eur J Pharmacol; 2008 Dec; 600(1-3):87-92. PubMed ID: 18930726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tachykinin NK(3) receptor agonists induced microvascular leakage hypersensitivity in the guinea-pig airways.
    Daoui S; Ahnaou A; Naline E; Emonds-Alt X; Lagente V; Advenier C
    Eur J Pharmacol; 2001 Dec; 433(2-3):199-207. PubMed ID: 11755153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.